Literature DB >> 25271311

Disease severity in chronic graft-versus-host disease: doctors' gut feeling versus biostatistics?

Gerard Socié1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25271311      PMCID： PMC4181247          DOI： 10.3324/haematol.2014.113878

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

1.  Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy.

Authors:  José A Pérez-Simón; Cristina Encinas; Fernando Silva; Maria José Arcos; María Díez-Campelo; Fermín M Sánchez-Guijo; Enrique Colado; Jesús Martín; Lourdes Vazquez; Consuelo Del Cañizo; Dolores Caballero; Jesús San Miguel
Journal:  Biol Blood Marrow Transplant       Date:  2008-10       Impact factor: 5.742

2.  Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease.

Authors:  Yoshihiro Inamoto; Paul J Martin; Barry E Storer; Jeanne Palmer; Daniel J Weisdorf; Joseph Pidala; Mary E D Flowers; Mukta Arora; Madan Jagasia; Sally Arai; Xiaoyu Chai; Steven Z Pavletic; Georgia B Vogelsang; Stephanie J Lee
Journal:  Haematologica       Date:  2014-07-04       Impact factor: 9.941

3.  Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study.

Authors:  Z Kuzmina; S Eder; A Böhm; E Pernicka; L Vormittag; P Kalhs; V Petkov; G Stary; J Nepp; R Knobler; U Just; K Krenn; N Worel; H T Greinix
Journal:  Leukemia       Date:  2011-09-16       Impact factor: 11.528

4.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

5.  Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

Authors:  Sally Arai; Madan Jagasia; Barry Storer; Xiaoyu Chai; Joseph Pidala; Corey Cutler; Mukta Arora; Daniel J Weisdorf; Mary E D Flowers; Paul J Martin; Jeanne Palmer; David Jacobsohn; Steven Z Pavletic; Georgia B Vogelsang; Stephanie J Lee
Journal:  Blood       Date:  2011-07-26       Impact factor: 22.113

6.  Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.

Authors:  Gérard Socié; Claudia Schmoor; Wolfgang A Bethge; Hellmut D Ottinger; Matthias Stelljes; Axel R Zander; Liisa Volin; Tapani Ruutu; Dominik A Heim; Rainer Schwerdtfeger; Karin Kolbe; Jiri Mayer; Johan A Maertens; Werner Linkesch; Ernst Holler; Vladimir Koza; Martin Bornhäuser; Hermann Einsele; Hans-Jochem Kolb; Hartmut Bertz; Matthias Egger; Olga Grishina; Jürgen Finke
Journal:  Blood       Date:  2011-04-05       Impact factor: 22.113

7.  The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation.

Authors:  S Thepot; J Zhou; A Perrot; M Robin; A Xhaard; R P de Latour; L Ades; P Ribaud; A D Petropoulou; R Porcher; G Socié
Journal:  Leukemia       Date:  2010-09-09       Impact factor: 11.528

8.  Feasibility of NIH consensus criteria for chronic graft-versus-host disease.

Authors:  B-S Cho; C-K Min; K-S Eom; Y-J Kim; H-J Kim; S Lee; S-G Cho; D-W Kim; J-W Lee; W-S Min; C-C Kim
Journal:  Leukemia       Date:  2008-10-02       Impact factor: 11.528

Review 9.  Current issues in chronic graft-versus-host disease.

Authors:  Gérard Socié; Jerome Ritz
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.